Professor Richard Warren

Professor Richard Warren

Consultant Dermatologist

BSc (Hons), MBChB (Hons), MRCP PhD, FRCP

I am widely recognised as one of the worlds leading dermatologists with my major interest being medical dermatology managing inflammatory conditions such as psoriasis, acne and eczema. I also have decades of experience in the diagnosis and management of skin cancer. I have over 300 peer review publications including first author publications The Lancet and New England Journal of Medicine. I have led on the development of numerous new therapies for treating a variety of skin diseases which have revolutionised many people's lifes.

I am both Professor of Dermatology at The University of Manchester and a fully trained Consultant Dermatologist working at the major Dermatology Centre in the North West, Salford Royal Care org.

I am a full member of the British Association of Dermatologists and listed on the General Medical Council specialist medical register and have many UK and Global leadership roles in dermatology.

I am the lead clinician and in the world renowned psoriasis service at Salford and have established specialist clinics for patients suffering from acne and eczema. 

Read more...

Treatment information

Some of the principal treatments carried out by Professor Richard Warren at Spire include:

Dermatology

Other treatments

  • Dermatological surgery and allergies
  • Dermatology
  • Inflammatory skin disease
  • Skin cancer

Get in touch

7625
True
consultant

Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

We will use your personal information to process your enquiry. For further information, please see our privacy policy.

Submit my enquiry

Additional information

Dermatology

Special clinical interests: Inflammatory skin disease (psoriasis, acne and eczema), skin cancer, skin surgery, allergies and skin lesions

My research interests are into the genetic basis of psoriasis and eczema and new and emerging treatments for these conditions, for which I have received both national and international awards. I regularly publish on these topics, with over 250 peer reviewed publications, including the major general medical journals such as The Lancet.

Alongside this I sit on a national committee related to the use of “biologicals” (a new form of treatment for psoriasis) and I am involved in the production of national guidelines related to the treatment of psoriasis.

I have a strong track record on delivering high calibre lectures and have over the last 15 years been a plenary speaker and invited chair at the premier international and national dermatology meetings, both in the clinical and research fields (eg World Congress; American Academy of Dermatology; European Academy of Dermatology and Venereology; British Society of Investigative Dermatology). Additionally, I have been an invited speaker at the Royal College of Physicians and The Royal Society of Medicine as well as many others. These invitations demonstrate an international reputation in my research field and the feedback provided demonstrates the educational value of my lecture content.


Articles

An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Efficacy and safety of emerging immunotherapies in psoriasis

Consultant Dermatologist, Salford Royal NHS Foundation Trust and The University of Manchester.

Director of the clinical trials unit at The University of Manchester.

I try to balance my busy work schedule with family life. I am married to Natalie and we have two young boys, Ben and Sam, and a dog called Meg. I have a keen interest in sport and try to keep fit when I can.